Adhera Therapeutics Appoints T - GuruFocus.com
GuruFocus Article or News written by GuruFocusNews and the topic is about:
Source: gurufocus.com
Melior Discovery News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Melior Discovery. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Melior Discovery Today - Breaking & Trending Today
Adhera Therapeutics Names Preeminent Diabetes Pioneer Dr.
Baton Rouge, LA, March 21, 2022 (GLOBE NEWSWIRE) -- Adhera Therapeutics, Inc. (OTCPK: ATRX) ("Adhera" or the "Company"), a clinical stage...
Source: globenewswire.com
Manufacturing Commences on Adhera's MLR-1019 for Phase 2a Clinical Trial Treating Parkinson's Disease
Baton Rouge, LA, Oct. 15, 2021 (GLOBE NEWSWIRE) — Adhera Therapeutics, Inc. (OTCPK: ATRX) (“Adhera” or the “Company”), a clinical stage biopharmaceutical company, today announces that manufacturing has commenced of MLR-1019 (armesocarb) for use in the Company’s planned Phase 2a clinical trial as a new therapeutic for Parkinson’s disease (PD). Adhera is also pleased to inform shareholders that a new patent has been issued covering MLR-1019 in Korea. Adhera is actively working to initiate a Phase 2a study designed to be a multi-center, double blind, randomized, ...
Source: assistivetechnologyblog.com
7 Biotech Penny Stocks With Huge Catalysts Coming in 2022
With a new year fast approaching, these biotech penny stocks may benefit from the shifting winds in the broader healthcare market.
Source: investorplace.com